Delayed Initiation of ECMO Is Associated With Poor Outcomes in Patients With Severe COVID-19: A Multicenter Retrospective Cohort Study

Background: Extracorporeal membrane oxygenation (ECMO) is a rapidly evolving therapy for acute lung and/or heart failure. However, the information on the application of ECMO in severe coronavirus disease 2019 (COVID-19) is limited, such as the initiation time. Especially in the period and regions of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xuyan, Hu, Ming, Zheng, Ruiqiang, Wang, Yishan, Kang, Hanyujie, Jiang, Li, Zhong, Ming, Sang, Ling, Zheng, Xia, Pan, Chun, Zhang, Wei, Qiu, Haibo, Du, Bin, Tong, Zhaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481658/
https://www.ncbi.nlm.nih.gov/pubmed/34604257
http://dx.doi.org/10.3389/fmed.2021.716086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481658/
https://www.ncbi.nlm.nih.gov/pubmed/34604257
http://dx.doi.org/10.3389/fmed.2021.716086

Ejemplares similares